期刊文献+

缺血性心肌病患者血红蛋白水平、细胞因子、神经内分泌激素及左室功能的相关性研究 被引量:1

Relationship between hemoglobin concentration,cytokine,neurohormonal activation and cardiacfunction in anemicpatients with ischemic cardiomyopathy
原文传递
导出
摘要 目的探讨缺血性心肌病(ICM)患者血红蛋白水平、细胞因子、神经内分泌激素及心功能变化的相关性。方法测定入选121例慢性充血性心力衰竭(CHF)患者的血红蛋白(Hb)水平、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和血管紧张素Ⅱ(AngⅡ)的变化;超声心动图测量左室射血分数(LVEF),评价心功能;按Hb水平分为ICM贫血组和非贫血组,同时选择27例正常人作为对照组。结果ICM贫血组TNF-α、IL-6和AngⅡ水平明显高于非贫血组,而LVEF显著低于非贫血组(P<0.01);随着TNF-α、IL-6和AngⅡ水平升高,Hb和LVEF明显降低(P<0.01);ICM患者Hb水平和LVEF与TNF-α、IL-6和AngⅡ水平呈负相关,Hb水平与LVEF呈正相关(P<0.01)。结论ICM患者神经内分泌激素和细胞因子激活影响并促进贫血与心力衰竭的病理生理过程。 Objective To study the relationships between hemoglobin concentration, cytokine, neurohormonal activation and cardiacfunction in anemicpatients with ischemic cardiomyopathy. Methods Hemoglobin concentration, serum TNF- α, IL- 6 and Ang Ⅱ in 121 patients with ischemic eardiomyopathy were measured,left ventrieular ejection fraction (LVEF) by eehoeardio-graphy, according to hemoglobin concentration, these patients was distributed the Anemic group and the Non - Anemic group, contrasting to 27 good health person. Results The levels of serum TNF - α, IL - 6 and Ang Ⅱ in the anemic patients group were-higher than those in the non - anemic group subjects, but LVEF were lower. With the increase of anemia severity, the levels of serum TNF - α, IL - 6 and Ang Ⅱ significantly increased ; there was a positive correlation between LVEF and the levels of serum TNF-α,IL- 6 and Ang Ⅱ ( P 〈 0.01 ), and a negative correlation between LVEF and Hb concentration. Conclusion The levels of cytokine, neurohormonal activation promote the pathophysiological procedure between cardiac failure and anemicin ICM.
出处 《临床医学》 CAS 2009年第5期94-96,共3页 Clinical Medicine
关键词 缺血性心肌病 血红蛋白 细胞因子 血管紧张素Ⅱ 左室功能 Ischemic cardiomyopathy Hemoglobin concentration Cytokine Neurohormonal activation Cardiac function
  • 相关文献

参考文献10

  • 1王鸣和,王骏.缺血性心肌病的研究近况[J].国际心血管病杂志,2007,34(1):1-5. 被引量:28
  • 2上海市心力衰竭调查协作组.上海市1980、1990、2000年心力衰竭住院患者流行病学及治疗状况调查[J].中华心血管病杂志,2002,30(1):24-27. 被引量:195
  • 3Chaudhry FA,lskendran AE.Assessing myocardial viability in ischemic cardiomyopathy[J].Echocardiography,2005,22(1):57.
  • 4Inder SA.Anemia and chronic heart failure:implications and treatment options[J].J Am Coll Cardiol,2008,52(7):501-511.
  • 5Kamran A,Pearlman BL.Congestive heart failure-related anemia and a role for erythropoietin[J].Int J Cardiol,2007,117(3):296-305.
  • 6陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 7Westenbrink BD,Ruifrok WP,De Boer RA,et al.Erythropoietin restores cardiac function in heart failure by promoting vascular endothelial growth factor expression in cardiomyocytes[J].Eur J Heart Fail,2008,7(Sup 1):150-151.
  • 8Francesca M,Alberto L,Giulio C,et al.Erythropoietin in heart and vessels:focus on transcription and signalling pathways[J].J Thromb Thrombolysis,2008 (3):13.
  • 9Lipsic E,Schoemaker RG,van der Meer P,et al.Protective effects of erythropoietin in cardiac ischemia[J].J Am Coll Cardiol,2006,48:2161-2167.
  • 10Kamran A,Brian L,Pearlman.Congestive heart failure-related anemia and a role for erythropoietin[J].Int J Cardiol,2007,117(3):296-305.

二级参考文献28

  • 1[1]Chaudhry FA,Iskendrin AE.Assessing myocardial viability in ischemic cardiomyopathy[J].Echocardiography,2005,22 (1):57.
  • 2[2]Cleland JG,Pennell DJ,Ray SG,et al.Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial):randomized,controlled trial[J].Lancet,2003,362 (9377):14-21.
  • 3[3]Bito V,Heinzel FR,Weidemann F,et al.Cellular mechanisms of contractile dysfunction in hibernating myocardium[J].CircRes,2004,94(6):794-801.
  • 4[4]van der Velden J,Merkus D,Klarenbeek BR,et al.Alterations in myofilarnent fun ction contribute to left ventricular dysfunction in pigs early after myocardial infarction[J].Circ Res,2004,95(11):e85-e95.
  • 5[5]Canty JM Jr,Fallavollita JA.Hibernating myocardium[J].J Nucl Cardiol,2005,12(1):104-119.
  • 6[6]Wilhelmi MH,Leyh RG,Wilhelmi M,et al.Upregulation of endothelial adhesion molecules in hearts with congestive and ischemic cardiomyopathy:immunohistochemical evaluation of inflammatory endothelial cell activation[J].Eur J Cardiothorac Surg,2005,27(1):122-127.
  • 7[7]Bree D,Wollmuth JR,Cupps BP,et al.Low-dose dobutamine tissue-tagged ma gnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy[J].Circulation,2006,114(1 Suppl):Ⅰ33-Ⅰ36.
  • 8[8]Bhatia G,Sosin M,Leahy JF,et al.Hibernating myocardiun in heart failure[J].Expert Rev Cardiovasc Ther,2005,3 (1):111-122.
  • 9[9]Kokaji K,Okamoto M,Hotoda K,et al.Experience with nifekalant hydrochloride in a patient with ischemic cardiomyopathy and severe ventricular dysfunction after dor operation[J].Jpn Heart J,2004,45 (4):691-695.
  • 10[10]Monti LD,Setola E,Fragasso G,et al.Metabolic and endo thelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic Cardiomyopathy[J].Am J physiol Endocrinol Metab,2006,290 (1):e54-e59.

共引文献3005

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部